BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9605573)

  • 1. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
    Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
    Wurch T; Palmier C; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
    Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
    Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Eur J Pharmacol; 1998 Jun; 351(2):193-201. PubMed ID: 9687003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
    J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
    Pauwels PJ; Palmier C; Wurch T; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
    Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
    J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor.
    Haenisch B; Bönisch H
    Pharmacogenet Genomics; 2011 Jul; 21(7):432-5. PubMed ID: 21478802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
    Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
    J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand.
    Bonaventure P; Schotte A; Cras P; Leysen JE
    Recept Channels; 1997; 5(3-4):225-30. PubMed ID: 9606727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.